2919216-33-2
2919216-33-2
Chemical Structure
CDK2-IN-9
- CAS No.: 2919216-33-2
- Formula:C21H16ClN3O4S
- Molecular Weight:441.89
IUPAC Name: 4-chloro-N-(4-oxo-2-(phenoxymethyl)quinazolin-3(4H)-yl)benzenesulfonamide
InChIKey: BLIIAZQONXFAMI-UHFFFAOYSA-N
SMILES: O=S(C1=CC=C(Cl)C=C1)(NN2C(COC3=CC=CC=C3)=NC4=C(C=CC=C4)C2=O)=O
Biological Activity: CDK2-IN-9 is a potent CDK2 inhibitor with an IC50 of 0.63 µM. CDK2-IN-9 shows antiproliferative activity. CDK2-IN-9 induces apoptosis and cell cycle arrest at S and G2/M phase. CDK2-IN-9 has the potential for the research of melanoma[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CDK2-IN-9 | CDK2-IN-9 is a potent CDK2 inhibitor with an IC50 of 0.63 µM. CDK2-IN-9 shows antiproliferative activity. CDK2-IN-9 induces apoptosis and cell cycle arrest at S and G2/M phase. CDK2-IN-9 has the potential for the research of melanoma. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
